Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
INBKZ
Undervalued
First Internet Bancorp
Price$25.32
Model IV$30.41
P/IV0.83
Discount 17%
Return to IV: +20.1%
INBS
Deeply overvalued
INTELLIGENT BIO SOLUTIONS INC.
Price$2.13
Model IV$0.66
P/IV3.89
Premium +223%
Return to IV: -69.0%
Market implies +9.1%/yr
vs model +11.4% · in line
INBX
Valuation N/A
Inhibrx Biosciences, Inc.
Price$105.61
Model IV—
P/IV—
Market implies +150.0%/yr
vs model +2.0% · above model
INCR
Valuation N/A
Intercure Ltd.
Price$5.16
Model IV—
P/IV—
INCY
Undervalued
INCYTE CORP
Price$125.31
Model IV$168.99
P/IV0.57
Discount 26%
Return to IV: +34.9%
Market implies +7.3%/yr
vs model +14.5% · below model
INDB
Deeply overvalued
INDEPENDENT BANK CORP
Price$82.74
Model IV$62.38
P/IV1.27
Premium +33%
Return to IV: -24.6%
INDI
Fairly valued
indie Semiconductor, Inc.
Price$3.08
Model IV$3.35
P/IV1.49
Discount 8%
Return to IV: +8.7%
Market implies +5.0%/yr
vs model +45.6% · below model
INDO
Valuation N/A
Indonesia Energy Corp Ltd
Price$3.15
Model IV—
P/IV—
Market implies +39.1%/yr
vs model +0.0% · above model
INDP
Valuation N/A
Indaptus Therapeutics, Inc.
Price$3.14
Model IV—
P/IV—
INDV
Valuation N/A
Indivior Pharmaceuticals, Inc.
Price$34.49
Model IV—
P/IV—
Market implies -5.4%/yr
vs model +15.0% · below model
INEO
Deeply undervalued
INNEOVA Holdings Ltd
Price$0.55
Model IV$1.99
P/IV0.28
Discount 72%
Return to IV: +260.4%
Owner yield 40.5%
10-yr IRR 52.6% · steady
Market implies -19.5%/yr
vs model +4.8% · below model
INFQ
Valuation N/A
Infleqtion, Inc.
Price$13.12
Model IV—
P/IV—
INFU
Fairly valued
InfuSystem Holdings, Inc
Price$12.15
Model IV$10.28
P/IV0.88
Premium +18%
Return to IV: -15.4%
Owner yield 7.0%
10-yr IRR 16.2% · moderate
Market implies +8.6%/yr
vs model +10.3% · in line
INFY
Valuation N/A
Infosys Ltd
Price$11.07
Model IV—
P/IV—
ING
Valuation N/A
ING GROEP NV
Price$36.96
Model IV—
P/IV—
INGM
Undervalued
Ingram Micro Holding Corp
Price$27.55
Model IV$36.09
P/IV0.78
Discount 24%
Return to IV: +31.0%
Market implies -1.4%/yr
vs model +3.0% · below model
INGN
Deeply undervalued
Inogen Inc
Price$5.31
Model IV$9.60
P/IV0.68
Discount 45%
Return to IV: +80.7%
Market implies -12.7%/yr
vs model +2.0% · below model
INGR
Deeply undervalued
Ingredion Inc
Price$100.49
Model IV$209.60
P/IV0.48
Discount 52%
Return to IV: +108.6%
Owner yield 12.2%
10-yr IRR 20.3% · steady
Market implies -5.3%/yr
vs model +4.0% · below model
INHD
Valuation N/A
INNO HOLDINGS INC.
Price$3.96
Model IV—
P/IV—
Market implies +42.4%/yr
vs model +0.0% · above model
INKT
Valuation N/A
MiNK Therapeutics, Inc.
Price$12.00
Model IV—
P/IV—
INLF
Deeply undervalued
INLIF Ltd
Price$2.96
Model IV$5.27
P/IV0.72
Discount 44%
Return to IV: +77.9%
Market implies -18.5%/yr
vs model +40.4% · below model
INLX
Deeply undervalued
INTELLINETICS, INC.
Price$5.50
Model IV$12.61
P/IV0.50
Discount 56%
Return to IV: +129.2%
Market implies -22.8%/yr
vs model +9.7% · below model
INM
Deeply undervalued
InMed Pharmaceuticals Inc.
Price$1.30
Model IV$11.60
P/IV0.14
Discount 89%
Return to IV: +791.9%
Market implies -49.8%/yr
vs model +26.9% · below model
INMB
Valuation N/A
Inmune Bio, Inc.
Price$2.22
Model IV—
P/IV—
Market implies +123.8%/yr
vs model +2.0% · above model
INMD
Deeply undervalued
InMode Ltd.
Price$14.89
Model IV$21.34
P/IV0.65
Discount 30%
Return to IV: +43.3%
Owner yield 13.4%
10-yr IRR 25.5% · moderate
Market implies +0.5%/yr
vs model +7.6% · below model
INN
Fairly valued
Summit Hotel Properties, Inc.
Price$5.59
Model IV$5.29
P/IV1.09
Premium +6%
Return to IV: -5.3%
INNV
Deeply overvalued
InnovAge Holding Corp.
Price$10.75
Model IV$2.09
P/IV3.63
Premium +414%
Return to IV: -80.5%
Market implies +28.8%/yr
vs model +8.3% · above model
INO
Valuation N/A
INOVIO PHARMACEUTICALS, INC.
Price$1.25
Model IV—
P/IV—
Market implies +101.8%/yr
vs model +2.0% · above model
INOD
Deeply overvalued
INNODATA INC
Price$53.21
Model IV$30.22
P/IV3.47
Premium +76%
Return to IV: -43.2%
Market implies +15.7%/yr
vs model +37.8% · below model
INR
Deeply undervalued
INFINITY NATURAL RESOURCES, INC.
Price$14.92
Model IV$59.30
P/IV0.23
Discount 75%
Return to IV: +297.4%
Market implies -12.4%/yr
vs model +8.0% · below model
INSE
Overvalued
Inspired Entertainment, Inc.
Price$5.10
Model IV$4.32
P/IV1.78
Premium +18%
Return to IV: -15.3%
Owner yield 12.1%
10-yr IRR 26.3% · moderate
Market implies +8.8%/yr
vs model +10.8% · in line
INSG
Deeply overvalued
INSEEGO CORP.
Price$4.47
Model IV$7.80
P/IV1.68
Discount 43%
Return to IV: +74.6%
Market implies -5.6%/yr
vs model +2.0% · below model
INSM
Deeply overvalued
INSMED Inc
Price$119.92
Model IV$23.52
P/IV4.55
Premium +410%
Return to IV: -80.4%
Market implies +13.6%/yr
vs model +33.9% · below model
INSP
Deeply undervalued
Inspire Medical Systems, Inc.
Price$73.00
Model IV$180.13
P/IV0.23
Discount 59%
Return to IV: +146.8%
Market implies -16.3%/yr
vs model +40.6% · below model
INSW
Deeply undervalued
International Seaways, Inc.
Price$103.65
Model IV$529.26
P/IV0.15
Discount 80%
Return to IV: +410.6%
Owner yield 9.7%
10-yr IRR 25.9% · grower
Market implies -2.4%/yr
vs model +24.6% · below model
INTA
Deeply overvalued
Intapp, Inc.
Price$37.49
Model IV$15.02
P/IV1.54
Premium +150%
Return to IV: -59.9%
Market implies +27.0%/yr
vs model +20.3% · above model
INTC
Valuation N/A
INTEL CORP
Price$108.60
Model IV—
P/IV—
Market implies +43.5%/yr
vs model +0.0% · above model
INTG
Deeply overvalued
INTERGROUP CORP
Price$37.74
Model IV$20.31
P/IV1.91
Premium +86%
Return to IV: -46.2%
INTJ
Deeply overvalued
Intelligent Group Ltd
Price$3.00
Model IV$3.51
P/IV2.71
Discount 15%
Return to IV: +17.0%
Market implies -13.4%/yr
vs model +15.0% · below model
INTR
Valuation N/A
Inter & Co, Inc.
Price$5.71
Model IV—
P/IV—
INTS
Valuation N/A
INTENSITY THERAPEUTICS, INC.
Price$3.98
Model IV—
P/IV—
INTT
Deeply overvalued
INTEST CORP
Price$11.42
Model IV$4.63
P/IV3.64
Premium +147%
Return to IV: -59.4%
Owner yield 5.5%
10-yr IRR 11.3% · moderate
Market implies +17.1%/yr
vs model +8.3% · above model
INTU
Deeply undervalued
INTUIT INC.
Price$303.19
Model IV$713.19
P/IV0.44
Discount 57%
Return to IV: +135.2%
Owner yield 5.4%
10-yr IRR 14.8% · grower
Market implies -0.5%/yr
vs model +13.4% · below model
INTZ
Valuation N/A
INTRUSION INC
Price$0.89
Model IV—
P/IV—
Market implies +41.8%/yr
vs model +2.0% · above model
INUV
Deeply undervalued
Inuvo, Inc.
Price$0.62
Model IV$5.53
P/IV0.29
Discount 89%
Return to IV: +793.5%
Market implies -48.4%/yr
vs model +9.6% · below model
INV
Valuation N/A
Innventure, Inc.
Price$0.94
Model IV—
P/IV—
Market implies +49.2%/yr
vs model +50.0% · in line
INVA
Deeply undervalued
Innoviva, Inc.
Price$20.66
Model IV$64.08
P/IV0.33
Discount 68%
Return to IV: +210.2%
Owner yield 10.0%
10-yr IRR 19.0% · moderate
Market implies -9.4%/yr
vs model +6.5% · below model
INVE
Deeply overvalued
Identiv, Inc.
Price$2.58
Model IV$0.87
P/IV4.73
Premium +198%
Return to IV: -66.4%
Market implies +10.8%/yr
vs model +2.0% · above model
INVH
Deeply undervalued
Invitation Homes Inc.
Price$26.91
Model IV$57.71
P/IV0.51
Discount 53%
Return to IV: +114.5%
Market implies -3.7%/yr
vs model +6.9% · below model
INVX
Deeply undervalued
Innovex International, Inc.
Price$29.08
Model IV$118.71
P/IV0.23
Discount 76%
Return to IV: +308.2%
Owner yield 5.4%
10-yr IRR 16.2% · grower
Market implies -1.5%/yr
vs model +24.2% · below model
INVZ
Valuation N/A
Innoviz Technologies Ltd.
Price$0.30
Model IV—
P/IV—
Market implies +23.4%/yr
vs model +8.0% · above model
IONQ
Valuation N/A
IonQ, Inc.
Price$36.75
Model IV—
P/IV—
Market implies +55.1%/yr
vs model +50.0% · above model
IONR
Valuation N/A
ioneer Ltd
Price$2.79
Model IV—
P/IV—
IONS
Valuation N/A
IONIS PHARMACEUTICALS INC
Price$54.21
Model IV—
P/IV—
Market implies +9.6%/yr
vs model +3.9% · above model
IOR
Deeply overvalued
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/
Price$18.50
Model IV$8.94
P/IV2.01
Premium +107%
Return to IV: -51.7%
IOSP
Fairly valued
INNOSPEC INC.
Price$93.23
Model IV$75.22
P/IV1.10
Premium +24%
Return to IV: -19.3%
Market implies +6.8%/yr
vs model +4.7% · in line
IOT
Deeply overvalued
Samsara Inc.
Price$41.65
Model IV$19.32
P/IV1.81
Premium +116%
Return to IV: -53.6%
Market implies +10.8%/yr
vs model +39.4% · below model
IOTR
Undervalued
iOThree Ltd
Price$2.02
Model IV$2.57
P/IV1.52
Discount 21%
Return to IV: +27.1%
Market implies -2.5%/yr
vs model +50.0% · below model
IOVA
Valuation N/A
IOVANCE BIOTHERAPEUTICS, INC.
Price$8.60
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +15.0% · below model
IP
Deeply overvalued
INTERNATIONAL PAPER CO /NEW/
Price$34.53
Model IV$25.01
P/IV1.34
Premium +38%
Return to IV: -27.6%
Owner yield 2.5%
10-yr IRR -1.5% · steady
Market implies +8.8%/yr
vs model +5.1% · above model
